MC
Merck & Co Portfolio holdings
AUM
$276M
1-Year Est. Return
29.78%
This Fund
S&P 500
1 Year Est. Return
+29.78%
AUM
$276M
AUM Growth
+$48.2M
(+21%)
Holding
13
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$627M
| $112M | 40.47% |
14,044,943
|
|
||
2
Moderna
MRNA
$19.3B
| $68.1M | 24.64% |
2,308,190
|
|
||
3
Kymera Therapeutics
KYMR
$6.96B
| $60.1M | 21.75% |
772,165
|
|
||
4
Entrada Therapeutics
TRDA
$266M
| $17.9M | 6.47% |
1,739,768
|
|
||
|
EVAX
5
Evaxion A/S
EVAX
$33.9M
| $5.79M | 2.1% |
1,214,126
|
|
||
6
Alector
ALEC
$271M
| $5.53M | 2% |
3,545,719
|
|
||
7
Sutro Biopharma
STRO
$660M
| $3.15M | 1.14% |
272,351
|
|
||
8
Viridian Therapeutics
VRDN
$1.75B
| $2.91M | 1.05% |
93,414
|
|
||
9
Xilio Therapeutics
XLO
$46.7M
| $950K | 0.34% |
105,983
|
|
||
|
CARM
10
DELISTED
Carisma Therapeutics
CARM
| $63.3K | 0.02% |
1,473,240
|
|
||
|
NEUP
11
Neuphoria Therapeutics
NEUP
$28.8M
| $38.9K | 0.01% |
10,027
|
|
||
|
HURA
12
TuHURA Biosciences
HURA
$153M
| $10.6K | ﹤0.01% |
13,950
|
|
||
|
LVTX
13
DELISTED
LAVA Therapeutics
LVTX
| – | – |
-1,149,345
|
|